In this propensity-matched study, the incidence and severity of postoperative acute kidney injury, the incidence of renal-replacement therapy, 30-day mortality, and the change of postoperative platelet count did not differ between patients receiving 6% HES 130/0.4 and those receiving albumin on the day of surgery. This evidence concerns the gene ALB and acute kidney injury.